June 20, 2013
Sanofi (EURONEXT: SAN and NYSE: SNY) and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer. The aim of the collaboration between Sanofi and Curie-Cancer is to revisit the basic...
June 18, 2013
The Novartis Prizes for Immunology are awarded to three scientists for their groundbreaking research into the biology of immune system T cells that advanced the prevention and treatment of a variety of diseases. The Prize ceremony will take place at the 15th International Congress of Immunology in Milan, Italy on August 23, 2013. The Novartis Prize for Basic...
June 17, 2013
- An antibiotic has been found to stimulate its own production. The findings, to be published in PNAS, could make it easier to scale up antibiotic production for commercialisation. Scientists Dr Emma Sherwood and Professor Mervyn Bibb from the John Innes Centre were able to use their discovery of how the antibiotic is naturally produced to markedly increase the level of production. "We have shown for the first time that an antibiotic with clinical potential can act as signalling molecule to...
June 14, 2013
- Lifestyle factors, lack of awareness by both patients and physicians, hesitancy in initiating and intensifying drug treatment, and healthcare structural deficiencies are amongst the reasons for the increasing problem of high blood pressure in Europe, according to new joint Guidelines issued today by the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). The Guidelines, which recommend several significant changes to hypertension treatment, are launched* today at...
June 12, 2013
- Driven by innovations like the industry itself, analytica will feature a new attraction when it opens in April 2014: For the first time ever, there will be a special show on occupational health and safety in the laboratory. Successful concepts such as the Live Labs and the renowned analytica Conference will also be continued. While everyone waited with great anticipation for the innovative addition to last year's trade fair, i.e. the Live Labs, the new topic on the 2014 program of events is...
June 11, 2013
The European Medicines Agency has released the sixth revision of the guideline on the acceptability of names for human medicinal products processed through the centralised procedure for public consultation. The current update of this guideline provides further recommendations on the requirements for acceptability and...
June 10, 2013
- African medicinal plants contain chemicals that may be able to stop the spread of cancer cells. This is the conclusion of researchers following laboratory experiments conducted at Johannes Gutenberg University Mainz (JGU). The plant materials will now undergo further analysis in order to evaluate their therapeutic potential. "The active substances present in African medicinal plants may be capable of killing off tumor cells that are resistant to more than one drug. They thus represent an...
June 6, 2013
- For some species, living twice as long in good health depends on no more than a few genes. When this fact was revealed by studies on worms three decades ago, it ushered in a golden age of ageing studies that has delivered numerous results, but also sown some confusion. The prestigious journal Cell is now publishing an exhaustive review of the subject that aims to set things straight and "serve as a framework for future studies." All the molecular indicators of ageing in mammals - the nine...
June 5, 2013
- The project will optimize treatment of cancer patients based on the cancers’ individual genetic fingerprint. Intomics will use its leading biomedical data analysis capabilities to help choose the right treatment from cancer-derived genetic information. The project receives €3.0M in financial support from The Danish National Advanced Technology Foundation. Two cancer patients may respond very differently to the same treatment if their genetic cancer fingerprints differ. Mutations in genes...
June 4, 2013
- Researchers at the University of Cambridge have discovered that a single mutation in a leukemia-associated gene reduces the ability of blood stem cells to make more blood stem cells, but leaves their progeny daughter cells unaffected. Their findings have relevance to all cancers that are suspected to have a stem cell origin as they advance our understanding of how single stem cells are subverted to cause tumors. Published this week in PLOS Biology, the study by Professor Tony Green and his team...